 Patients with histologically or cytologically documented squamous cell carcinoma of the head and neck SCCHN eligible primary sites: oral cavity, oropharynx, hypopharyx, or larynx presenting with locally recurrent andor metastatic disease, with at least 1 unidimensionally or bidimensionally measurable lesion. 